Prognostic value of a 46-gene cell cycle progression (CCP) RNA signature for prostate cancer death in a conservatively managed watchful waiting needle biopsy cohort.
J. M. Cuzick
Research Funding - Myriad Genetics
G. Fisher
Research Funding - Myriad Genetics
D. Berney
No relevant relationships to disclose
D. Mesher
Research Funding - Myriad Genetics
H. Møller
No relevant relationships to disclose
J. E. Reid
Employment or Leadership Position - Myriad Genetics
A. Gutin
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
J. S. Lanchbury
Employment or Leadership Position - Myriad Genetics
S. Stone
Employment or Leadership Position - Myriad Genetics